| Literature DB >> 15965285 |
Mevlut Kurt1, Ibrahim K Onal, Tamer Elkiran, Bulent Altun, Kadri Altundag, Ibrahim Gullu.
Abstract
We report the case of a 52-yr-old man with metastatic lung adenocarcinoma who developed tumor lysis syndrome after administration of zoledronic acid. Tumor lysis syndrome in solid tumors and the antitumor effect of the zolendronic acid are discussed in light of the pertinent literature.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15965285 DOI: 10.1385/MO:22:2:203
Source DB: PubMed Journal: Med Oncol ISSN: 1357-0560 Impact factor: 3.064